|1||Not yet recruiting||
Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
|2||Active, not recruiting||
Carotid Atherosclerosis In Newly Diagnosed Type 2 Individuals
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
† Study has passed its completion date and status has not been verified in more than two years.